Ligne de temps
Vincent Bondet
Ingénieur(e) de Recherche
17 nov. 2024
12 nov. 2024
publication
Increased mortality in diffuse systemic sclerosis patients with high circulating IFNα levels.
Lire plus11 oct. 2024
02 sept. 2024
28 août 2024
publication
Hereditary C1q Deficiency is Associated with Type 1 Interferon-Pathway Activation and a High Risk of Central Nervous System Inflammation.
Lire plus15 nov. 2023
news
New publication – Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses
Lire plus09 août 2023
01 août 2023
12 mai 2023
publication
JAK Inhibition in Aicardi-Goutières Syndrome: a Monocentric Multidisciplinary Real-World Approach Study.
Lire plus01 avr. 2023
publication
Central Role of Macrophages and Nucleic Acid Release in Myasthenia Gravis Thymus.
Lire plus17 janv. 2023
publication
Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNα and B cell subsets.
Lire plus05 déc. 2022
publication
Juvenile Neuropsychiatric Systemic Lupus Erythematosus: Identification of Novel Central Neuroinflammation Biomarkers.
Lire plus25 nov. 2022
publication
Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity.
Lire plus15 nov. 2022
publication
Enhanced TLR3 responsiveness in hepatitis C virus resistant women from the Irish anti-D cohort.
Lire plus28 juin 2022
publication
Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activation.
Lire plus20 juin 2022
publication
Variability of Primary Sjögren’s Syndrome Is Driven by Interferon-α and Interferon-α Blood Levels Are Associated With the Class II HLA-DQ Locus.
Lire plus09 juin 2022
publication
Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming.
Lire plus18 avr. 2022
publication
CXCR3 Expression Pattern on CD4+ T Cells and IP-10 Levels with Regard to the HIV-1 Reservoir in the Gut-Associated Lymphatic Tissue.
Lire plus31 mars 2022
publication
Activation of NLRP3 Inflammasome in the Skin of Patients with Systemic and Cutaneous Lupus Erythematosus.
Lire plus28 mars 2022
news
New publication – Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC transplanted SCID patients with IL2RG/JAK3 deficiency
Lire plus23 févr. 2022
publication
Efficacy and tolerance of corticosteroids and methotrexate in patients with juvenile dermatomyositis: a retrospective cohort study.
Lire plus14 févr. 2022
publication
Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC transplanted SCID patients with IL2RG/JAK3 deficiency.
Lire plus01 févr. 2022
publication
Primary immune responses are negatively impacted by persistent herpesvirus infections in older people: results from an observational study on healthy subjects and a vaccination trial on subjects aged more than 70 years old.
Lire plus01 janv. 2022
publication
Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses.
Lire plus01 sept. 2021
publication
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.
Lire plus23 août 2021
publication
Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection.
Lire plus01 août 2021
04 juin 2021
publication
Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients.
Lire plus01 mai 2021
publication
HIV DNA reservoir and elevated PD-1 expression of CD4 T-cell subsets particularly persist in the terminal ileum of HIV-positive patients despite cART.
Lire plus01 avr. 2021
publication
Differential Expression of Interferon-Alpha Protein Provides Clues to Tissue Specificity Across Type I Interferonopathies.
Lire plus12 févr. 2021
publication
JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study.
Lire plus01 févr. 2021
publication
Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients.
Lire plus04 janv. 2021
publication
TLR3 controls constitutive IFN-β antiviral immunity in human fibroblasts and cortical neurons.
Lire plus01 janv. 2021
publication
Altered Immune Phenotypes and HLA-DQB1 Gene Variation in Multiple Sclerosis Patients Failing Interferon β Treatment.
Lire plus01 janv. 2021
02 nov. 2020
publication
Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signaling.
Lire plus24 sept. 2020
publication
Dysregulation of tryptophan catabolism at the host-skin microbiota interface in Hidradenitis Suppurativa.
Lire plus19 sept. 2020
publication
Absence of Neuronal Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus.
Lire plus13 juil. 2020
publication
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
Lire plus02 juil. 2020
22 juin 2020
publication
Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome.
Lire plus19 juin 2020
publication
Catatonia in a patient with Aicardi-Goutières syndrome efficiently treated with immunoadsorption.
Lire plus05 juin 2020
publication
Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes.
Lire plus05 mars 2020
publication
The proteome of neutrophils in sickle cell disease reveals an unexpected activation of interferon alpha signaling pathway
Lire plus01 janv. 2020
publication
Decreased Type I Interferon Production by Plasmacytoid Dendritic Cells Contributes to Severe Dengue.
Lire plus13 déc. 2019
publication
Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in
Lire plus26 nov. 2019
26 nov. 2019
22 nov. 2019
publication
Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling
Lire plus30 oct. 2019
publication
Use of ruxolitinib in COPA syndrome manifesting as life-threatening alveolar haemorrhage
Lire plus30 oct. 2019
publication
Inhibition of IFNα secretion in cells from patients with juvenile dermatomyositis under TBK1 inhibitor treatment revealed by single-molecular assay technology
Lire plus05 oct. 2019
publication
Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers
Lire plus05 sept. 2019
publication
Circulating interferon-α measured with a highly sensitive assay as a biomarker for juvenile inflammatory myositis activity
Lire plus22 août 2019
10 juil. 2019
publication
Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatment
Lire plus14 juin 2019
publication
Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles
Lire plus22 mai 2019
publication
IP-10 contributes to the inhibition of mycobacterial growth in an ex vivo whole blood assay
Lire plus08 avr. 2019
publication
Delineating the healthy human skin UV response and early induction of interferon pathway in cutaneous lupus erythematosus
Lire plus07 mars 2019
publication
Interferon signature in patients with STAT1 gain-of-function mutation is epigenetically determined
Lire plus18 févr. 2019
publication
Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth
Lire plus04 janv. 2019
06 déc. 2018
01 nov. 2018
03 oct. 2018
publication
Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency
Lire plus07 sept. 2018
publication
First description of agonist and antagonist IP-10 in urine of patients with active TB
Lire plus05 juil. 2018
publication
Interplay of DDP4 and IP-10 as a Potential Mechanism for Cell Recruitment to Tuberculosis Lesions
Lire plus14 juin 2018
publication
Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Lire plus01 juin 2018
publication
JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis
Lire plus01 juin 2018
publication
Comment on: ‘Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors’ by Giannelou : mutations in result in a constitutive activation of type I interferon signalling
Lire plus19 déc. 2017
20 avr. 2017
publication
TBK1/IKKE blockade inhibits mutant STING mediated inflammatory response in patient cells
Lire plus18 avr. 2017
publication
Detection of interferon alpha protein reveals differential levels and cellular sources in disease
Lire plus10 sept. 2015
10 sept. 2015
01 déc. 2013
publication
Structural and functional characterization of an orphan ATP-binding cassette ATPase involved in manganese utilization and tolerance in Leptospira spp.
Lire plus27 juil. 2007
publication